Back

Stroke rates in non-anticoagulated individuals with and without atrial fibrillation and one non-sex CHA2DS2-VASc risk factor: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Toward better risk stratification for stroke prevention in atrial fibrillation Stroke in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Mariam Anjum

Baerum Hospital, Baerum (Norway)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture in Toward better risk stratification for stroke prevention in atrial fibrillation.
Professor G. Lip (Liverpool, GB)
Slides Video
Presentation thumbnail
A synergistic impact of early rhythm control and lifestyle modification on the risk of stroke in patients with new-onset atrial fibrillation: a korean nationwide population-based cohort study
Doctor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Concluding State-Of-the-Art Lecture - How to bridge towards clinical application of novel better risk stratifications for stroke prevention in atrial fibrillation?
Professor T. Potpara (Belgrade, RS)
Slides Video

Access the full session

Session thumbnail
Toward better risk stratification for stroke prevention in atrial fibrillation
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation patients at intermediate risk of stroke rapidly progress to high stroke risk: A nationwide registry study (AFNOR).
thumbnail
Congress Presentation
State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources